Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Australian Healthcare Herald.
AI in Remote Patient Monitoring (RPM) Market to Reach USD 8,438.5 Million by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global AI in remote patient monitoring market, valued at US$1551.8 million in 2023, stood at US$1,967.7 million in 2024 and is projected to advance at a resilient CAGR of 27.5% from 2024 to...

Cell Dissociation Market Size Projected to Attain USD 1,451.89 Million by 2034
Ottawa, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global cell dissociation market size valued at USD 406.36 million in 2024, is projected to reach approximately USD 1,451.89 million by 2034, growing at a CAGR of 13.58%, according to a study by Towards...
Global Hearing Aids Market to Surpass USD 14.42 Billion by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Growing Prevalence of Hearing Loss and Smart Technology Adoption Fuel Sector Expansion The global hearing aids market, valued at US$9.74 billion in 2024, stood at US$10.35 billion in 2025 and is...

Genome Editing Market to Grow at 16.9% CAGR Through 2030
Boston, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Genome Editing: Technologies and Global Markets” is projected to grow from $10.8 billion in 2025 to $23.7 billion by the end of 2030, at a compound...

Anteris Announces Results for the Second Quarter of 2025
MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercialising...

Cocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Favorable CDI-988 Phase 1 safety and tolerability reported Challenge study with CDI-988 as a norovirus preventive and treatment planned later this year BOTHELL, Wash., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP)...

Medland Orthodontics Partners with Hismile to Elevate Patient Oral Care Experience
In a strategic new partnership, Medland Orthodontics teams up with global oral health brand Hismile to break down barriers in oral hygiene GOLD COAST, QUEENSLAND, AUSTRALIA, August 12, 2025 /EINPresswire.com/ -- In a move set to redefine the...

IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights
Announced clinical improvement in progression free survival observed in pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (pembrolizumab) for the treatment of first-line advanced melanoma, but statistical significance narrowly missed; company...

Global Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030
Boston, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Tissue Engineering and Regeneration: Technologies and Global Markets” is estimated to increase from $5.4 billion in 2025 to $9.8 billion by the end of...

Brewing Ingredients Market Size to Ferment to USD 71.50 Billion by 2034, Fueled by Steady 6.83% CAGR
The global brewing ingredients market size was approximately USD 42.15 billion in 2024 and is projected to reach around USD 71.50 billion by 2034 PUNE, MAHARASHTRA, INDIA, August 22, 2025 /EINPresswire.com/ -- Introduction Brewing ingredients...

Global Digital Pathology Market to Reach $13.7 Billion in 2029
Boston, Aug. 15, 2025 (GLOBE NEWSWIRE) -- As global demand for precision diagnostics rises, digital pathology is reshaping how clinical labs, research institutions, and healthcare systems operate. From AI-assisted image analysis to remote...

Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
Advancing novel programs for respiratory viruses that pose pandemic threats or risk of serious illness, including SARS CoV2 (ratutrelvir) and influenza (Tivoxavir marboxil, TXM) Prioritization of ratutrelvir, a ritonavir-free, protease inhibitor...

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Next-generation claudin 18.2 ISAC BDC-4182 now in Phase 1 dose-escalation study Cash balance of $48.5 million as of June 30, 2025 anticipated to fund key milestones through mid-2026 REDWOOD CITY, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bolt...

MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
Q2 Revenue of $11.8 Million, an Increase of 14% over Q2 2024 50% Growth in Revenue for International Medical Cannabis International Medical sales now 57% of Total Revenue Cash Balance of $10.4 Million at the end of Q2, Increased from $8.4 Million...

Larimar Therapeutics Reports Second Quarter 2025 Financial Results
Initial data from the 50 mg dose in the open label study and the adolescent PK run-in study planned for program update in September 2025 Adolescent participants from the PK run-in study and patients with FA who have not participated in prior...

Microbix Reports Results for Q3 Fiscal 2025
MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and nine months of fiscal 2025 ended...

X1 Plumb Launches ‘Plumb it Forward’ Initiative for Melbourne Residents in Need
MELBOURNE, VICTORIA, AUSTRALIA, August 14, 2025 /EINPresswire.com/ -- X1 Plumb has launched its “Plumb it Forward” community initiative, a program designed to provide free essential plumbing and gas fitting services to Melbourne residents...

Sleep Electric Bringing Mobile Adjustable Bed Showroom to Brisbane South Residents' Doorsteps for Almost 10 Years
BRISBANE, QUEENSLAND, AUSTRALIA, August 15, 2025 /EINPresswire.com/ -- Sleep Electric has operated its mobile adjustable bed showroom service to Brisbane South for almost 10 years, allowing local residents to explore and trial electric beds in...

Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
~ Achieved Second Quarter 2025 Total Net Revenues of $9.7 Million ~ ~ Double Digit New Accounts in the Second Quarter of 2025, Including Notable Quarter-Over-Quarter Growth in Both Large Community Practices and Academic Centers, Supported by...

Prescription Delivery Service Market to Reach $32.61 Billion by 2029 with 0% CAGR
The Business Research Company’s Prescription Delivery Service Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 23, 2025 /EINPresswire.com/ -- What Is The Prescription Delivery...